NI, Yong,PARIKH, Bhavnish,YELESWARAM, Krishnaswamy,ERICKSON-VIITANEN, Susan,WILLIAMS, William V.
申请号：
PH12019501070
公开号：
PH12019501070A1
申请日:
2019.05.14
申请国别(地区):
PH
年份:
2020
代理人:
摘要：
The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
